TriSalus Life Sciences, Inc. (TLSI) Earnings History
Annual and quarterly earnings data from 2020 to 2025
Loading earnings history...
TLSI EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TLSI Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 84.6% | -59.7% | -154.3% |
| 2024 | 86.1% | -122.9% | -112.9% |
| 2023 | 85.9% | -294.3% | -320.7% |
| 2022 | 81.8% | -293.9% | -380.6% |
| 2021 | 85.8% | -286.1% | -343.4% |
Download Data
Export TLSI earnings history in CSV or JSON format
Free sign-in required to download data
TriSalus Life Sciences, Inc. (TLSI) Earnings Overview
As of May 8, 2026, TriSalus Life Sciences, Inc. (TLSI) reported trailing twelve-month net income of -$39M, reflecting -47.2% year-over-year growth. The company earned $-0.84 per diluted share over the past four quarters, with a net profit margin of -154.3%.
Looking at the long-term picture, TLSI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$29M in fiscal 2021.
TriSalus Life Sciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), ANGO (-$28M net income, -11.6% margin), IRTC (-$28M net income, -6.0% margin), TLSI has room to improve margins relative to the peer group. Compare TLSI vs NVCR →
TLSI Earnings vs Peers
Earnings metrics vs comparable public companies
TLSI Historical Earnings Data (2020–2025)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$70M | -109.7% | -$27M | $-1.84 | -154.3% | -59.7% |
| 2024 | -$33M | +44.0% | -$36M | $-1.25 | -112.9% | -122.9% |
| 2023 | -$59M | -25.8% | -$54M | $-2.23 | -320.7% | -294.3% |
| 2022 | -$47M | -63.6% | -$36M | $-1.59 | -380.6% | -293.9% |
| 2021 | -$29M | +9.4% | -$24M | $-0.92 | -343.4% | -286.1% |
| 2020 | -$32M | - | $-108,493 | $-0.02 | - | - |
See TLSI's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TLSI Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TLSI vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTLSI — Frequently Asked Questions
Quick answers to the most common questions about buying TLSI stock.
Is TLSI growing earnings?
TLSI EPS fell to $-0.84, with earnings declining -47.2%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-39M.
What are TLSI's profit margins?
TriSalus Life Sciences, Inc. net margin is -154.3%, with operating margin at -59.7%. Below-average margins reflect competitive or cost pressures.
How consistent are TLSI's earnings?
TLSI earnings data spans 2020-2025. The declining earnings trend is -47.2% YoY. Historical data enables comparison across business cycles.